Literature DB >> 9581891

The HIV type 1 coreceptor CCR5 and its role in viral transmission and disease progression.

W A Paxton1, S Kang, R A Koup.   

Abstract

The purified CD4+ lymphocytes of a group of highly exposed but HIV-1-uninfected individuals were determined to be less susceptible to infection with multiple non-syncytium-inducing (NSI) primary isolates of HIV-1 than were CD4+ lymphocytes from nonexposed control individuals. This relative resistance to HIV-1 infection did not extend to T cell line-adapted or syncytium-inducing (SI) primary viral isolates, was restricted by the envelope glycoprotein, and was associated with an increased production of the C-C chemokines RANTES, MIP-1alpha, and MIP-1beta. The block to replication in CD4+ lymphocytes from two exposed-uninfected subjects was at the point of entry, as was the block imposed by the recombinant C-C chemokines RANTES, MIP-1alpha, and MIP-1beta. Resistance to infection and the high production of beta chemokines were characteristic of every CD4+ lymphocyte clone from the exposed-uninfected subjects. We have now identified the mechanism underlying this in vitro and in vivo resistance to infection: These individuals have inherited a homozygous 32-bp nucleotide deletion (delta32) within the gene encoding the coreceptor for primary NSI isolates of HIV-1 (CCR5). This deletion encodes a severely truncated and unstable protein that is not expressed on the cell surface. This allele is common in the Caucasian population, with a frequency of 0.0808, but is not found in people of African or Asian ancestry. To determine its role in HIV-1 transmission and disease progression, we analyzed the CCR5 genotype of 1252 homosexual men enrolled in the Chicago component of the Multicenter AIDS Cohort Study (MACS). No infected participant was found to be homozygous for the delta32 allele whereas 3.6% of at-risk but uninfected Caucasian participants were homozygous, showing the highly protective role of this genotype against sexual acquisition of HIV-1. No evidence was found to suggest that heterozygotes were protected against HIV-1 infection, but a limited protective role against disease progression was noted. The delta32 allele of CCR5 is therefore an important host factor in HIV-1 transmission and pathogenesis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9581891

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  8 in total

Review 1.  Weighing the Evidence of Efficacy of Oral PrEP for HIV Prevention in Women in Southern Africa.

Authors:  Holly Janes; Lawrence Corey; Gita Ramjee; Lindsay N Carpp; Carl Lombard; Myron S Cohen; Peter B Gilbert; Glenda E Gray
Journal:  AIDS Res Hum Retroviruses       Date:  2018-06-19       Impact factor: 2.205

Review 2.  Greater risk for HIV infection of black men who have sex with men: a critical literature review.

Authors:  Gregorio A Millett; John L Peterson; Richard J Wolitski; Ron Stall
Journal:  Am J Public Health       Date:  2006-05-02       Impact factor: 9.308

3.  HIV-1 resistance to maraviroc conferred by a CD4 binding site mutation in the envelope glycoprotein gp120.

Authors:  Annette N Ratcliff; Wuxian Shi; Eric J Arts
Journal:  J Virol       Date:  2012-11-07       Impact factor: 5.103

Review 4.  Virus and target cell evolution in human immunodeficiency virus type 1 infection.

Authors:  D E Mosier
Journal:  Immunol Res       Date:  2000       Impact factor: 2.829

5.  Donor- and ligand-dependent differences in C-C chemokine receptor 5 reexpression.

Authors:  R Sabbe; G R Picchio; C Pastore; O Chaloin; O Hartley; R Offord; D E Mosier
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

6.  Herpes simplex virus 2 serostatus and viral loads of HIV-1 in blood and semen as risk factors for HIV transmission among men who have sex with men.

Authors:  David M Butler; Davey M Smith; Edward R Cachay; George K Hightower; Charles Thomas Nugent; Douglas D Richman; Susan J Little
Journal:  AIDS       Date:  2008-08-20       Impact factor: 4.177

7.  Resistance to the CCR5 inhibitor 5P12-RANTES requires a difficult evolution from CCR5 to CXCR4 coreceptor use.

Authors:  Rebecca Nedellec; Mia Coetzer; Michael M Lederman; Robin E Offord; Oliver Hartley; Donald E Mosier
Journal:  PLoS One       Date:  2011-07-08       Impact factor: 3.240

Review 8.  Genetic variation in the chemokine receptor 5 gene and course of HIV infection; review on genetics and immunological aspect.

Authors:  M K Verma; S Shakya
Journal:  Genes Dis       Date:  2020-04-18
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.